Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab

Autor:	Lawrence L. Horstman, Wenche Jy, Joaquin J. Jimenez, Zoneddy Ruiz-Dayao, Yeon S. Ahn, Edgardop S. Santos, Daniel H. Kett, Teresa Gagliano-DeCesare
Rok vydání:	2003
Předmět:	Pacemaker Artificial Anticorps monoclonal medicine.drug_class medicine.medical_treatment B-Lymphocyte Subsets Hemorrhage Factor VIIa Platelet Transfusion Postoperative Hemorrhage Monoclonal antibody Compartment Syndromes Autoimmune Diseases Antibodies Monoclonal Murine-Derived Refractory Fviii inhibitor Coagulopathy medicine Bradycardia Humans Deamino Arginine Vasopressin Aged Autoantibodies Aged 80 and over Hematoma Factor VIII Blue Toe Syndrome business.industry Antibodies Monoclonal Immunoglobulins Intravenous Hematology General Medicine Immunotherapy Plasmapheresis Factor VII medicine.disease Antigens CD20 Combined Modality Therapy Recombinant Proteins Immunology Aminocaproic Acid Rituximab Female business medicine.drug
Zdroj:	Acta haematologica. 109(4)
ISSN:	0001-5792
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9c9a6ec70f4a48ced55b760b8cd88a https://pubmed.ncbi.nlm.nih.gov/12853696 Zobrazit plný text záznamu